Study to Assess the Effects and Safety of ZGN-1061 in Overweight and Obese Participants With Type 2 Diabetes

NCT03254368 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

188

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 2 Diabetes Mellitus
Overweight and Obesity

Interventions

DRUG: ZGN-1061
DRUG: Placebo

Sponsor

Zafgen, Inc.